Preferred Label : Bevacizumab/Carboplatin/Pemetrexed Regimen;
NCIt synonyms : Avastin/Carboplatin/Alimta; Bevacizumab-Carboplatin-Pemetrexed; Bevacizumab-Carboplatin-Pemetrexed Regimen; Bevacizumab/Carboplatin/Pemetrexed;
NCIt related terms : Carboplatin, Pemetrexed, Bevacizumab; Carboplatin, Pemetrexed, Bevacizumab-bvzr; Carboplatin, Pemetrexed, Bevacizumab-onbe; Carboplatin, Pemetrexed, Bevacizumab-maly; Carboplatin, Pemetrexed, Bevacizumab-aybi; Carboplatin, Pemetrexed, Bevacizumab-adcd; Carboplatin, Pemetrexed, Bevacizumab-equi; Carboplatin, Pemetrexed, Bevacizumab-awwb; Carboplatin, Pemetrexed, Bevacizumab-tnjn;
NCIt definition : A regimen consisting of bevacizumab, carboplatin and pemetrexed that is used for the
treatment of non-small cell lung cancer (NSCLC).;
NCI Metathesaurus CUI : CL523592;
Codes from synonyms : 30050; 127487; 127413; 127635; 127339; 127561; 127265; 127191; 142168;
Origin ID : C136281;
UMLS CUI : C4526549;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
